Ren Y, Gao X Y, Wang H Y, Yang B, Zhao D D, Huang D, Su M, Li L
Department of Neonatology, Xuzhou Central Hospital, Xuzhou School of Clinical Medicine of Nanjing Medical University, Xuzhou 221009, China.
Zhonghua Er Ke Za Zhi. 2021 Feb 2;59(2):113-118. doi: 10.3760/cma.j.cn112140-20200818-00807.
To explore the predictive value of platelet aggregation rate in patent ductus arteriosus in preterm infants. This prospective nested case-control study enrolled 72 preterm infants with gestational age<32 weeks, who were admitted to Neonatal Intensive Care Unit of Xuzhou Central Hospital from August 2017 to October 2019. The echocardiography was performed on the 4 to 5 day after birth, and the preterm infants who met the diagnostic criteria of hemodynamically significant patent ductus arteriosus (hsPDA) were included into hsPDA group, and the control group was comprised of matched preterm infants with non-hsPDA according to the proportion of 1∶2. The basic characteristics of the preterm infants were recorded, and their complete blood counts and platelet aggregation function were examined. Clinical data were compared by student's test and chi-square test between the two groups. The risk factors and their predictive values were analyzed by binary logistic regression analysis and receiver operating characteristic curve. There were 24 preterm infants (16 boys) in the hsPDA group, and 48 (30 boys) in the control group. The incidence of neonatal respiratory distress syndrome (NRDS) grade II-IV in the hsPDA group was higher than that in the control group (67% (16/24) 27% (13/48), χ²10.422, =0.001). The thrombocytocrit and adenosine diphosphate-induced platelet aggregation rate in the hsPDA group were lower than those in the control group (0.002 1±0.000 9 0.002 8±0.000 9, 0.21±0.10 0.32±0.07, =-3.043 and -5.093, =0.004 and <0.01, respectively); while the platelet volume in the hsPDA group was greater than that in the control group ((10.3±2.4) (9.2±2.0) fl, = 2.713, = 0.033). The other platelet parameters (platelet count, platelet distribution width, and large platelet ratio) and platelet aggregation rate induced by other inducers (collagen, epinephrine and arachidonic acid) were not significantly different between the two groups (all >0.05). The low platelet aggregation rate induced by adenosine diphosphate and low thrombocytocrit were independent risk factors for hsPDA in preterm infants (=4.525 and 3.994, 95%: 1.305-15.689 and 1.143-13.958, respectively). And the adenosine diphosphate-induced platelet aggregation rate had moderate predictive value for hsPDA in preterm infants, as the area under the receiver operating characteristic curve was 0.809, and the cutoff value was 0.245 with 0.67 sensitivity and 0.86 specificity. Poor platelet aggregation function and low thrombocytocrit are independent risk factors for hsPDA in preterm infants with gestational age<32 weeks. Low platelet aggregation rate induced by adenosine diphosphate has moderate predictive value for hsPDA patency.
探讨血小板聚集率对早产儿动脉导管未闭的预测价值。本前瞻性巢式病例对照研究纳入了72例孕周<32周的早产儿,这些早产儿于2017年8月至2019年10月入住徐州市中心医院新生儿重症监护病房。在出生后4至5天进行超声心动图检查,将符合血流动力学显著动脉导管未闭(hsPDA)诊断标准的早产儿纳入hsPDA组,对照组按照1∶2的比例由匹配的非hsPDA早产儿组成。记录早产儿的基本特征,并检测其全血细胞计数和血小板聚集功能。两组间临床资料采用t检验和卡方检验进行比较。通过二元逻辑回归分析和受试者工作特征曲线分析危险因素及其预测价值。hsPDA组有24例早产儿(16例男婴),对照组有48例(30例男婴)。hsPDA组新生儿Ⅱ - Ⅳ级呼吸窘迫综合征(NRDS)的发生率高于对照组(67%(16/24)对27%(13/48),χ² = 10.422,P = 0.001)。hsPDA组的血小板压积和二磷酸腺苷诱导的血小板聚集率低于对照组(0.002 1±0.000 9对0.002 8±0.000 9,0.21±0.10对0.32±0.07,t = -3.043和 -5.093,P = 0.004和<0.01);而hsPDA组的血小板体积大于对照组((10.3±2.4)对(9.2±2.0)fl,t = 2.713,P = 0.033)。两组间其他血小板参数(血小板计数、血小板分布宽度和大血小板比率)以及其他诱导剂(胶原纤维、肾上腺素和花生四烯酸)诱导的血小板聚集率差异均无统计学意义(均>0.05)。二磷酸腺苷诱导的低血小板聚集率和低血小板压积是早产儿hsPDA的独立危险因素(t = 4.525和3.994,95%可信区间:分别为1.305 - 15.689和1.143 - 13.958)。二磷酸腺苷诱导的血小板聚集率对早产儿hsPDA具有中等预测价值,受试者工作特征曲线下面积为0.809,截断值为0.245,敏感性为0.67,特异性为0.86。血小板聚集功能差和血小板压积低是孕周<32周早产儿hsPDA 的独立危险因素。二磷酸腺苷诱导的低血小板聚集率对hsPDA通畅具有中等预测价值。